A fraught question for the children of Alzheimer’s: Is it coming for us?
In the latest edition of STAT's Health Tech newsletter: How doctors and nurses s...
In a new study, scientists sought to engineer bird flu resistance in chickens.
Want to stay on top of the science and politics driving biotech today? Sign up t...
Contract manufacturers are investing billions to expand or build factories to fi...
Akero Therapeutics said Tuesday that an experimental medicine failed to show a s...
New research shows how AI models can become a victim of their own success, sendi...
The state of Connecticut expects to spend more than $30 million on GLP-1s in 202...
Learning the hard way how to live with a rare inherited immunodeficiency, chroni...
Despite advances in prevention, stroke deaths are projected to near 10 million g...
Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics fr...
The FDA rejected an Alnylam therapy for an increasingly prevalent heart disease,...
Taking aim at a major killer, the well-funded startup Delfi Diagnostics launches...
STAT spoke with the global head of Boehringer Ingelheim's innovation unit, about...
JMIR Public Health and Surveillance Editor-in-Chief: Travis Sanchez and guest ed...
BATON ROUGE – Five Pennington Biomedical Research Center faculty members and one...
